查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1390425

脫髮治療市場：2023-2028 年全球產業趨勢、佔有率、規模、成長、機會與預測

Alopecia Treatment Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
出版日期: | 出版商: IMARC | 英文 139 Pages | 商品交期: 2-3個工作天內

價格

概要

2022年，全球脫髮治療市場規模達到31億美元。展望未來， IMARC Group預計到2028年市場規模將達到41億美元，2022-2028年複合年成長率（CAGR）為4.77%。脫髮率的不斷上升、人們對脫髮狀況和治療方法的認知不斷增強、醫療技術和治療方法的進步以及政府支持性政策的實施是推動市場發展的一些主要因素。

脫髮治療是指用於控制和對抗脫髮的各種方法，脫髮是一種以嚴重脫髮為特徵的疾病。脫髮的類型包括雄性禿、斑禿和疤痕性脫髮。脫髮治療包括局部治療、口服藥物、植髮手術、光療法和富血小板血漿療法。它有助於減緩脫髮進展、促進頭髮再生、保持頭髮健康、改善外觀並增強自信。

脫髮（包括雄性禿和斑禿）盛行率的上升是推動有效治療需求的關鍵因素之一。此外，提供具有成本效益的毛髮移植手術的國家的醫療旅遊業不斷成長，也推動了市場的成長。此外，快速的城市化，加上可支配收入的增加，使個人能夠負擔得起高品質的治療計劃，也促進了市場的成長。除此之外，製藥公司透過社群媒體和有影響力的行銷來提高消費者對新產品和治療方法的認知，採取積極的行銷和促銷策略，有利於市場成長。此外，遠距醫療的出現使獲得醫療諮詢和處方變得更加容易，這正在加強市場的成長。其他因素，包括對個人化醫療不斷成長的需求、廣泛的研發 (R&D) 活動以及時尚和娛樂產業影響力的不斷上升，預計將推動市場成長。

脫髮治療市場趨勢/促進因素：

脫髮症的盛行率日益增加

脫髮包括一系列脫發病症，在全球範圍內越來越普遍。其誘因包括遺傳傾向、荷爾蒙失衡、壓力和生活方式因素，如營養不良、吸煙、接觸化學物質和久坐的生活方式。這些觸發因素正在增加，尤其是在老化人口和在高壓力環境中工作的個人。與此一致的是，由於現代生活的快節奏和壓力，壓力引起的脫髮明顯增加。同時，隨著人口的成長和遺傳特徵的傳遞，與遺傳密切相關的雄性禿等疾病變得越來越普遍。此外，多囊性卵巢症候群（PCOS）和甲狀腺疾病等慢性疾病的盛行率不斷上升，這些疾病可能導致脫髮，也導致脫髮病例數量不斷增加。

人們對脫髮狀況和治療的認知不斷增強

由於網路上提供的資訊激增以及透過協調一致的宣傳活動，消費者對脫髮狀況的認知不斷增強，這是推動市場成長的關鍵因素之一。各種健康平台、社交媒體和有影響力的社區正在積極討論脫髮及其影響和可能的補救措施，使這個話題不再那麼禁忌，更容易被大眾所理解。這種意識的提高引發了態度的轉變，導致人們更傾向於尋求專業協助和建議。人們對脫髮的污名化，加上人們認知到脫髮是一種可以治療的疾病，大大增加了對治療的需求。此外，知情的消費者更有可能長期堅持治療方案，這是另一個成長誘導因素。

醫療技術和治療方法的進步

毛髮學領域，即頭髮和頭皮的研究，近年來見證了重大的技術進步。增強型診斷工具的引入可以更準確地識別脫髮類型，從而提供更有針對性的治療，正在推動市場成長。此外，採用新的治療方案，包括低強度光療法和富血小板血漿療法，拓寬了治療範圍並改善了患者的治療結果。此外，最近開發的局部應用和口服創新藥物提高了脫髮治療的功效，也促進了市場的成長。這些進步豐富了消費者可用的治療選擇，並增強了他們對這些治療有效性的信心。因此，越來越多的人投資脫髮治療和治療，從而推動市場成長。

脫髮治療行業細分：

IMARC Group提供了全球脫髮治療市場報告各細分市場主要趨勢的分析，以及 2023-2028 年全球、區域和國家層面的預測。我們的報告根據藥物類型、適應症、性別、給藥途徑和配銷通路對市場進行了分類。

按藥物類型細分：

米諾地爾

非那雄胺

其他

米諾地爾佔據市場主導地位

該報告根據類型提供了詳細的市場細分和分析。這包括米諾地爾、非那雄胺等。報告稱，米諾地爾代表了最大的細分市場。

米諾地爾在市場上佔據主導地位，因為其有效性和安全性已在眾多臨床研究中得到充分證明，使其成為醫生和患者值得信賴的選擇。它也是少數在全球各個監管機構批准用於治療男性和女性型禿髮的療法之一。此外，它通常是局部應用的，並且可以輕鬆融入日常生活中。與手術治療相比，該應用的非侵入性性質吸引了許多患者。此外，米諾地爾有不同的形式，如泡沫、乳液和洗髮水，提供了一系列適合個人喜好的選擇。除此之外，它無需處方即可在櫃檯（OTC）獲得，這使得患者更容易獲得。

按指示細分：

雄性禿

斑禿

全禿

其他

雄性禿主導市場

該報告根據該指標提供了詳細的市場細分和分析。這包括雄性禿、斑禿、全禿等。根據該報告，雄性禿是最大的細分市場。

由於其高盛行率，雄性禿在脫髮治療市場上佔據主導地位。這是最常見的脫髮類型，影響很大一部分人口，尤其是隨著年齡的成長。此外，社會和個人認為脫髮是一種消極或不良狀況，這也推動了治療需求。頭髮通常與吸引力、年輕和健康聯繫在一起，因此脫髮會導致自尊和自信下降，促使人們尋求治療。此外，雄性禿具有很強的遺傳因素，如果不治療，往往會進展，使其成為長期、持續治療方法的目標。這提供了對治療產品和療法的穩定需求。除此之外，雄性禿治療方案的顯著進步，包括藥物和手術干預，是另一個生長誘導因素。

按性別分類：

男性

女性

女性主導市場

該報告根據性別對市場進行了詳細的細分和分析。這包括男性和女性。報告稱，女性代表了最大的細分市場。

由於社會壓力和美容標準，女性患者在市場上佔據主導地位，這使得她們更有可能尋求治療。此外，頭髮通常被視為女性身份和外表的重要組成部分，脫髮會對心理產生深遠的影響，導致自尊和自信下降。此外，與男性脫髮相比，女性脫髮有更多的治療選擇。其中包括荷爾蒙療法、局部治療和植髮，讓女性有更多機會找到適合她們的治療方法。此外，導致女性脫髮的因素比男性更廣泛，包括荷爾蒙變化、壓力、飲食、某些醫療狀況和藥物，導致更多女性脫髮。

依給藥途徑分類：

口服

專題

可注射

話題主導市場

該報告根據給藥途徑對市場進行了詳細的細分和分析。這包括口服、局部和注射。根據該報告，局部用藥代表了最大的細分市場。

局部給藥途徑在市場上佔據主導地位，因為它被用作防止脫髮的第一道防線。此外，局部治療是非侵入性的，通常患者耐受性良好。它們可以很容易地應用於受影響的區域，從而實現有針對性的治療。這種局部應用降低了全身副作用的風險，使其成為許多患者的更安全的選擇。此外，它們比頭髮移植和雷射治療等其他治療方案更實惠、更容易獲得。此外，它們很容易透過非處方藥 (OTC) 或處方獲得，這使患者更加方便。除此之外，局部治療的使用非常適合日常生活，因為患者可以在家中使用這些藥物，而無需定期去醫生辦公室或診所就診。這方面的便利性大大提高了患者的依從性，有助於提高治療效果。

按配銷通路分類：

醫院

零售藥局

網路藥局

醫院主導市場

該報告根據配銷通路對市場進行了詳細的細分和分析。這包括醫院、零售藥局和網路藥局。報告稱，醫院是最大的細分市場。

醫院由於提供廣泛的治療選擇（包括手術和非手術脫髮解決方案）而在脫髮治療市場佔據主導地位。此外，他們配備了最新的醫療設備和技術，使他們能夠提供先進的治療方法，如毛髮移植手術、雷射治療和類固醇注射。此外，醫院還聘請經驗豐富的工作人員和專業醫生，包括皮膚科醫生和毛髮科醫生，他們擅長診斷和治療不同類型的脫髮。這些專業人員能夠根據患者的個人情況指導患者選擇有效的治療方案。此外，他們還擁有內部藥房，使患者能夠更方便地獲得處方藥，從而提高對治療方案的依從性，從而獲得更好的結果。

按地區分類：

北美洲

美國

加拿大

亞太

中國

日本

印度

韓國

澳洲

印尼

其他

歐洲

德國

法國

英國

義大利

西班牙

俄羅斯

其他

拉丁美洲

巴西

墨西哥

其他

中東和非洲

北美在市場上表現出明顯的主導地位，佔據最大的脫髮治療市場佔有率

該報告還對所有主要區域市場進行了全面分析，其中包括北美（美國和加拿大）；亞太地區（中國、日本、印度、韓國、澳洲、印尼等）；歐洲（德國、法國、英國、義大利、西班牙、俄羅斯等）；拉丁美洲（巴西、墨西哥等）；以及中東和非洲。報告稱，北美是最大的細分市場。

由於斑禿和雄性禿的高發病率，北美在市場上佔據主導地位，這增加了對有效治療的需求。此外，由於衛生當局和公司進行廣泛的教育活動，人們對這種疾病和可用治療方法的認知不斷提高，這也促進了市場的成長。此外，該地區強大的醫療基礎設施和不斷成長的支出能力使患者更容易獲得高品質的治療。此外，這些治療方法的保險覆蓋範圍廣泛，對於讓更多人能夠負擔得起這些治療方法發揮關鍵作用。除此之外，該地區積極從事新療法研究和開發的主要製藥和生物技術公司的存在正在推動市場成長。

競爭格局：

市場主要參與者正在積極投資於研發 (R&D) 計劃，以發現創新、有效的脫髮治療方法。這包括開發新藥、新的應用技術以及從不同角度解決脫髮問題的治療方法，例如針對荷爾蒙水平、減少發炎或刺激毛囊。此外，領先公司還與生物技術公司、研究機構和大學建立策略夥伴關係和合作，以加快發現步伐並彙集資源和專業知識。此外，頂尖公司也致力於透過傳統和數位行銷管道提高消費者對各種脫髮治療的可用性和有效性的認知。此外，主要市場參與者正在進行嚴格的臨床試驗，以確保其產品符合嚴格的醫療標準和監管要求。

該報告對全球脫髮治療市場的競爭格局進行了全面分析。也提供了所有主要公司的詳細資料。市場上的一些主要參與者包括：

Aclaris 治療公司

賽爾米有限公司

西普拉有限公司

雷迪博士實驗室有限公司

葛蘭素史克公司

HCell公司

強生公司

默克公司

輝瑞公司

大正製藥控股股份有限公司

梯瓦製藥工業股份有限公司

最近的發展：

2022年8月，Aclaris Therapeutics Inc.宣布與禮來公司簽署非專屬專利授權協議，使用禮來公司的JAK抑制劑治療斑禿（AA）。

2021年9月，Dr. Reddy's Laboratories Ltd.推出了治療女性型禿頭（FPHL）的新藥

2023 年 6 月，FDA 批准了輝瑞公司名為 Litfulo 的新型口服療法，用於治療青少年脫髮。

本報告回答的關鍵問題

  • 2022年全球脫髮治療市場規模是多少
  • 2023-2028年全球脫髮治療市場的預期成長率是多少
  • 推動全球脫髮治療市場的關鍵因素是什麼
  • COVID-19 對全球脫髮治療市場有何影響
  • 根據藥物類型，全球脫髮治療市場的詳細情形如何
  • 根據適應症，全球脫髮治療市場的細分是什麼
  • 全球脫髮治療市場按性別分類的情況如何
  • 根據給藥途徑，全球脫髮治療市場的詳細情形如何
  • 基於配銷通路的全球脫髮治療市場的細分是什麼
  • 10. 全球脫髮治療市場的重點區域有哪些？
  • 11. 全球脫髮治療市場的主要參與者/公司有哪些？

本報告回答的關鍵問題

  • 2022年全球脫髮治療市場規模有多大？
  • 2023-2028年全球脫髮治療市場的預期成長率是多少？
  • 推動全球脫髮治療市場的關鍵因素是什麼？
  • COVID-19 對全球脫髮治療市場有何影響？
  • 根據藥物類型，全球脫髮治療市場的詳細情形如何？
  • 根據適應症，全球脫髮治療市場的詳細情形如何？
  • 全球脫髮治療市場按性別分類的情況如何？
  • 根據給藥途徑，全球脫髮治療市場的詳細情形如何？
  • 基於配銷通路的全球脫髮治療市場的細分是什麼？
  • 全球脫髮治療市場的關鍵地區有哪些？
  • 全球脫髮治療市場的主要參與者/公司有哪些？

目錄

第 1 章：前言

第 2 章：範圍與方法

  • 研究目的
  • 利害關係人
  • 資料來源
    • 主要資源
    • 二手資料
  • 市場預測
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第 3 章：執行摘要

第 4 章：簡介

  • 概述
  • 主要行業趨勢

第 5 章：全球脫髮治療市場

  • 市場概況
  • 市場業績
  • COVID-19 的影響
  • 市場預測

第 6 章：按藥物類型分類的市場細分

  • 米諾地爾
    • 市場走向
    • 市場預測
  • 非那雄胺
    • 市場走向
    • 市場預測
  • 其他
    • 市場走向
    • 市場預測

第 7 章：按跡象分類的市場

  • 雄性禿
    • 市場走向
    • 市場預測
  • 斑禿
    • 市場走向
    • 市場預測
  • 全禿
    • 市場走向
    • 市場預測
  • 其他
    • 市場走向
    • 市場預測

第 8 章：按性別分類的市場區隔

  • 男性
    • 市場走向
    • 市場預測
  • 女性
    • 市場走向
    • 市場預測

第 9 章：按管理途徑分類的市場

  • 口服
    • 市場走向
    • 市場預測
  • 專題
    • 市場走向
    • 市場預測
  • 可注射
    • 市場走向
    • 市場預測

第 10 章：按配銷通路分類的市場細分

  • 醫院
    • 市場走向
    • 市場預測
  • 零售藥局
    • 市場走向
    • 市場預測
  • 網路藥局
    • 市場走向
    • 市場預測

第 11 章：按地區分類的市場細分

  • 北美洲
    • 美國
      • 市場走向
      • 市場預測
    • 加拿大
      • 市場走向
      • 市場預測
  • 亞太
    • 中國
      • 市場走向
      • 市場預測
    • 日本
      • 市場走向
      • 市場預測
    • 印度
      • 市場走向
      • 市場預測
    • 韓國
      • 市場走向
      • 市場預測
    • 澳洲
      • 市場走向
      • 市場預測
    • 印尼
      • 市場走向
      • 市場預測
    • 其他
      • 市場走向
      • 市場預測
  • 歐洲
    • 德國
      • 市場走向
      • 市場預測
    • 法國
      • 市場走向
      • 市場預測
    • 英國
      • 市場走向
      • 市場預測
    • 義大利
      • 市場走向
      • 市場預測
    • 西班牙
      • 市場走向
      • 市場預測
    • 俄羅斯
      • 市場走向
      • 市場預測
    • 其他
      • 市場走向
      • 市場預測
  • 拉丁美洲
    • 巴西
      • 市場走向
      • 市場預測
    • 墨西哥
      • 市場走向
      • 市場預測
    • 其他
      • 市場走向
      • 市場預測
  • 中東和非洲
    • 市場走向
    • 按國家/地區分類的市場細分
    • 市場預測

第 12 章：SWOT 分析

  • 概述
  • 優勢
  • 弱點
  • 機會
  • 威脅

第 13 章：價值鏈分析

第 14 章：波特五力分析

  • 概述
  • 買家的議價能力
  • 供應商的議價能力
  • 競爭程度
  • 新進入者的威脅
  • 替代品的威脅

第 15 章：價格分析

第16章：競爭格局

  • 市場結構
  • 關鍵參與者
  • 關鍵參與者簡介
    • Aclaris Therapeutics Inc.
    • Cellmid Limited
    • Cipla Limited
    • Dr. Reddy's Laboratories Ltd.
    • GlaxoSmithKline plc
    • HCell Inc.
    • Johnson & Johnson
    • Merck & Co. Inc.
    • Pfizer Inc.
    • Taisho Pharmaceutical Holdings Co. Ltd
    • Teva Pharmaceutical Industries Ltd.
Product Code: SR112023A4147

Abstract

The global alopecia treatment market size reached US$ 3.1 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 4.1 Billion by 2028, exhibiting a growth rate (CAGR) of 4.77% during 2022-2028. The increasing prevalence of alopecia, growing awareness about hair loss conditions and treatments, advancements in medical technologies and therapeutics, and the implementation of supportive government policies are some of the major factors propelling the market.

Alopecia treatment refers to various methodologies used to manage and combat Alopecia, a condition characterized by significant hair loss. The types of alopecia include androgenetic alopecia, alopecia areata, and cicatricial alopecia. Alopecia treatment consists of topical treatments, oral medications, hair transplant surgery, light therapy, and platelet-rich plasma therapy. It aids in slowing down hair loss progression, promoting hair regrowth, maintaining healthy hair, improving physical appearance, and enhancing self-confidence.

The rising prevalence of alopecia, including androgenetic alopecia and alopecia areata, is one of the key factors driving the demand for effective treatments. In addition, the rising medical tourism to countries offering cost-effective hair transplant procedures is fueling the market growth. Furthermore, rapid urbanization, coupled with the increasing disposable income, which allows individuals to afford high-quality treatment plans is contributing to the market growth. Apart from this, the aggressive marketing and promotional strategies by pharmaceutical companies through social media and influencer marketing to enhance consumer awareness about new products and treatments is favoring the market growth. Moreover, the emergence of telemedicine, which enables easier access to medical consultations and prescriptions is strengthening the market growth. Other factors, including the growing demand for personalized medicine, extensive research and development (R&D) activities, and the rising influence of fashion and entertainment industries, are anticipated to drive the market growth.

Alopecia Treatment Market Trends/Drivers:

The increasing prevalence of alopecia

Alopecia, encompassing a spectrum of hair loss conditions, is increasingly prevalent across the globe. Its triggers, include genetic predispositions, hormonal imbalances, stress, and lifestyle factors, such as poor nutrition, smoking, exposure to chemicals, and sedentary lifestyle. These triggers are rising especially in ageing populations and individuals working in highly stressful environments. In line with this, stress-induced Alopecia has witnessed a noticeable upswing due to the rapid pace and pressures of modern living. Along with this, conditions such as androgenetic alopecia, which has a strong genetic link, are becoming more common as populations grow and genetic traits are passed on. Moreover, the increasing prevalence of chronic diseases, such as polycystic ovary syndrome (PCOS) and thyroid disorders, which can lead to hair loss, is also contributing to the rising number of Alopecia cases.

The growing awareness about hair loss conditions and Treatments

The growing consumer awareness regarding hair loss conditions owing to an explosion of information available online and through concerted awareness campaigns is one of key factors propelling the market growth. Various health platforms, social media, and influencer communities are actively discussing hair loss, its implications, and possible remedies, making the topic less taboo and more understood among the masses. This heightened awareness has triggered a shift in attitudes, leading to a higher propensity to seek professional help and advice. The destigmatization of hair loss, coupled with the understanding that Alopecia is a treatable condition, has substantially increased the demand for treatments. Moreover, informed consumers are more likely to persist with the treatment regime for an extended period, which is acting as another growth-inducing factor.

Advancements in medical technologies and therapeutics

The field of trichology, the study of hair and scalp, has witnessed significant technological advancements in recent years. The introduction of enhanced diagnostic tools, which allows more precise identification of the Alopecia type and, therefore, more targeted treatments is boosting the market growth. Additionally, the adoption of novel treatment options, including low-level light therapy and platelet-rich plasma therapy, has broadened the treatment spectrum and improved patient outcomes. Furthermore, the recent development of innovative drugs for topical application and oral ingestion, which has improved the efficacy of Alopecia treatment is contributing to the market growth. These advancements have enriched the array of treatment options available to consumers and boosted their confidence in the effectiveness of these treatments. As a result, more individuals are investing in Alopecia treatment and therapies, thus propelling the market growth.

Alopecia Treatment Industry Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the global alopecia treatment market report, along with forecasts at the global, regional and country levels from 2023-2028. Our report has categorized the market based on drug type, indication, gender, route of administration and distribution channel.

Breakup by Drug Type:

Minoxidil

Finasteride

Others

Minoxidil dominates the market

The report has provided a detailed breakup and analysis of the market based on the type. This includes minoxidil, finasteride, and others. According to the report, minoxidil represented the largest market segment.

Minoxidil is dominating the market because its effectiveness and safety have been well-documented in numerous clinical studies, making it a trusted option for both physicians and patients. It is also one of the few treatments approved by various regulatory bodies across the globe for treating male and female pattern baldness. Furthermore, it is typically applied topically and can be incorporated into daily routines without much hassle. The non-invasive nature of the application, compared to surgical treatments, appeals to many patients. Moreover, Minoxidil is available in different forms, such as foams, lotions, and shampoos, offering a range of options to fit individual preferences. Apart from this, it can be obtained over the counter (OTC) without a prescription, which makes it more accessible to patients.

Breakup by Indication:

Androgenic Alopecia

Alopecia Areata

Alopecia Totalis

Others

Androgenic alopecia dominates the market

The report has provided a detailed breakup and analysis of the market based on the indication. This includes androgenic alopecia, alopecia areata, alopecia totalis, and others. According to the report, androgenic alopecia represented the largest market segment.

Androgenic alopecia is dominating the alopecia treatment market due to its high prevalence. It is the most common type of hair loss, affecting a significant percentage of the population, especially with increasing age. In addition, societal and personal perceptions of hair loss as a negative or undesirable condition drive demand for treatment. Hair is often associated with attractiveness, youth, and health, so hair loss can lead to lower self-esteem and confidence, prompting individuals to seek treatment. Moreover, androgenic alopecia has a strong genetic component and tends to be progressive if not treated, making it a target for long-term, sustained treatment approaches. This offers a steady demand for treatment products and therapies. Apart from this, the significant advancements in the treatment options for androgenic alopecia, including both pharmaceutical and surgical interventions, are acting as another growth-inducing factor.

Breakup by Gender:

Male

Female

Female dominates the market

The report has provided a detailed breakup and analysis of the market based on gender. This includes male and female. According to the report, female represented the largest market segment.

Female patients are dominating the market due to societal pressures and beauty standards, making them more likely to seek treatment. In addition, hair is often seen as a significant part of a woman's identity and appearance, and hair loss can have a profound psychological impact, leading to lower self-esteem and confidence. Furthermore, there are more treatment options available for female-pattern hair loss compared to male-pattern baldness. These include hormone therapy, topical treatments, and hair transplantation, giving women more opportunities to find a treatment that works for them. Additionally, hair loss in women can be caused by a wider range of factors than in men, including hormonal changes, stress, diet, certain medical conditions, and medications, leading to a larger proportion of women experiencing hair loss.

Breakup by Route of Administration:

Oral

Topical

Injectable

Topical dominates the market

The report has provided a detailed breakup and analysis of the market based on the route of administration. This includes oral, topical, and injectable. According to the report, topical represented the largest market segment.

The topical route of administration is dominating the market as it is used as the first line of defense against hair loss. In addition, topical treatments are non-invasive and generally well-tolerated by patients. They can be easily applied to the affected area, allowing for targeted treatment. This localized application reduces the risk of systemic side effects, making it a safer option for many patients. Moreover, they are more affordable and accessible than other treatment options, such as hair transplants and laser treatments. Additionally, they are readily obtained over the counter (OTC) or through prescriptions, making them more convenient for patients. Apart from this, the use of topical treatments fits well into daily routines as patients can apply these medications at home, eliminating the need for regular visits to the doctor's office or clinic. This aspect of convenience greatly increases patient compliance, contributing to the efficacy of the treatment.

Breakup by Distribution Channel:

Hospitals

Retail Pharmacies

Online Pharmacies

Hospitals dominate the market

The report has provided a detailed breakup and analysis of the market based on distribution channel. This includes hospitals, retail pharmacies, and online pharmacies. According to the report, hospitals represented the largest market segment.

Hospitals are dominating the alopecia treatment market due to the wide range of treatment options they provide, including both surgical and non-surgical solutions for hair loss. In addition, they are equipped with the latest medical equipment and technologies, allowing them to provide advanced treatments such as hair transplantation surgeries, laser therapies, and steroid injections. Furthermore, hospitals employ experienced staff and specialized doctors, including dermatologists and trichologists, who are skilled in diagnosing and treating different types of alopecia. These professionals are able to guide patients toward effective treatment options based on their individual conditions. Additionally, they have in-house pharmacies, making it more convenient for patients to access prescribed medications, which improves adherence to treatment regimens, leading to better outcomes.

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

North America exhibits a clear dominance in the market, accounting for the largest alopecia treatment market share

The report has also provided a comprehensive analysis of all the major regional markets, which includes North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America represented the largest market segment.

North America is dominating the market due to a high prevalence of alopecia areata and androgenetic alopecia, which has increased the need for effective treatments. Additionally, the escalating awareness about the condition and available treatments owing to extensive educational campaigns by health authorities and companies is contributing to the market growth. Furthermore, the robust healthcare infrastructure and rising expenditure capacities in the region make it easier for patients to access high-quality treatment. In addition, the widespread availability of insurance coverage for these treatments plays a critical role in making them more affordable for a larger segment of the population. Apart from this, the presence of major pharmaceutical and biotech companies in the region that are actively engaged in the research and development of new treatments is boosting the market growth.

Competitive Landscape:

The key players in the market are actively investing in research and development (R&D) initiatives to discover innovative, effective treatments for alopecia. This includes the development of new drugs, novel application techniques, and treatments that tackle alopecia from different angles, such as targeting hormone levels, reducing inflammation, or stimulating hair follicles. Furthermore, leading companies are engaged in strategic partnerships and collaborations with biotech companies, research institutions, and universities to accelerate the pace of discovery and to pool resources and expertise. Additionally, the top companies are focusing on raising consumer awareness about the availability and effectiveness of various alopecia treatments through traditional and digital marketing channels. Moreover, key market players are conducting rigorous clinical trials to ensure their products meet stringent medical standards and regulatory requirements.

The report has provided a comprehensive analysis of the competitive landscape in the global alopecia treatment market. Detailed profiles of all major companies have also been provided. Some of the key players in the market include:

Aclaris Therapeutics Inc.

Cellmid Limited

Cipla Limited

Dr. Reddy's Laboratories Ltd.

GlaxoSmithKline plc

HCell Inc.

Johnson & Johnson

Merck & Co. Inc.

Pfizer Inc.

Taisho Pharmaceutical Holdings Co. Ltd

Teva Pharmaceutical Industries Ltd.

Recent Developments:

In Aug 2022, Aclaris Therapeutics Inc. announced a non-exclusive patent license agreement with Eli Lilly and Company to use Lilly's JAK inhibitor to treat alopecia areata (AA).

In September 2021, Dr. Reddy's Laboratories Ltd. launched a new drug to treat female pattern hair loss (FPHL)

In June 2023, FDA approved Pfizer's new oral treatment called Litfulo for treating alopecia in teens.

Key Questions Answered in This Report

  • 1. What was the size of the global alopecia treatment market in 2022?
  • 2. What is the expected growth rate of the global alopecia treatment market during 2023-2028?
  • 3. What are the key factors driving the global alopecia treatment market?
  • 4. What has been the impact of COVID-19 on the global alopecia treatment market?
  • 5. What is the breakup of the global alopecia treatment market based on the drug type?
  • 6. What is the breakup of the global alopecia treatment market based on the indication?
  • 7. What is the breakup of the global alopecia treatment market based on gender?
  • 8. What is the breakup of the global alopecia treatment market based on the route of administration?
  • 9. What is the breakup of the global alopecia treatment market based on the distribution channel?
  • 10. What are the key regions in the global alopecia treatment market?
  • 11. Who are the key players/companies in the global alopecia treatment market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Alopecia Treatment Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Drug Type

  • 6.1 Minoxidil
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Finasteride
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Others
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast

7 Market Breakup by Indication

  • 7.1 Androgenic Alopecia
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Alopecia Areata
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Alopecia Totalis
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Others
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast

8 Market Breakup by Gender

  • 8.1 Male
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Female
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast

9 Market Breakup by Route of Administration

  • 9.1 Oral
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Topical
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Injectable
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast

10 Market Breakup by Distribution Channel

  • 10.1 Hospitals
    • 10.1.1 Market Trends
    • 10.1.2 Market Forecast
  • 10.2 Retail Pharmacies
    • 10.2.1 Market Trends
    • 10.2.2 Market Forecast
  • 10.3 Online Pharmacies
    • 10.3.1 Market Trends
    • 10.3.2 Market Forecast

11 Market Breakup by Region

  • 11.1 North America
    • 11.1.1 United States
      • 11.1.1.1 Market Trends
      • 11.1.1.2 Market Forecast
    • 11.1.2 Canada
      • 11.1.2.1 Market Trends
      • 11.1.2.2 Market Forecast
  • 11.2 Asia-Pacific
    • 11.2.1 China
      • 11.2.1.1 Market Trends
      • 11.2.1.2 Market Forecast
    • 11.2.2 Japan
      • 11.2.2.1 Market Trends
      • 11.2.2.2 Market Forecast
    • 11.2.3 India
      • 11.2.3.1 Market Trends
      • 11.2.3.2 Market Forecast
    • 11.2.4 South Korea
      • 11.2.4.1 Market Trends
      • 11.2.4.2 Market Forecast
    • 11.2.5 Australia
      • 11.2.5.1 Market Trends
      • 11.2.5.2 Market Forecast
    • 11.2.6 Indonesia
      • 11.2.6.1 Market Trends
      • 11.2.6.2 Market Forecast
    • 11.2.7 Others
      • 11.2.7.1 Market Trends
      • 11.2.7.2 Market Forecast
  • 11.3 Europe
    • 11.3.1 Germany
      • 11.3.1.1 Market Trends
      • 11.3.1.2 Market Forecast
    • 11.3.2 France
      • 11.3.2.1 Market Trends
      • 11.3.2.2 Market Forecast
    • 11.3.3 United Kingdom
      • 11.3.3.1 Market Trends
      • 11.3.3.2 Market Forecast
    • 11.3.4 Italy
      • 11.3.4.1 Market Trends
      • 11.3.4.2 Market Forecast
    • 11.3.5 Spain
      • 11.3.5.1 Market Trends
      • 11.3.5.2 Market Forecast
    • 11.3.6 Russia
      • 11.3.6.1 Market Trends
      • 11.3.6.2 Market Forecast
    • 11.3.7 Others
      • 11.3.7.1 Market Trends
      • 11.3.7.2 Market Forecast
  • 11.4 Latin America
    • 11.4.1 Brazil
      • 11.4.1.1 Market Trends
      • 11.4.1.2 Market Forecast
    • 11.4.2 Mexico
      • 11.4.2.1 Market Trends
      • 11.4.2.2 Market Forecast
    • 11.4.3 Others
      • 11.4.3.1 Market Trends
      • 11.4.3.2 Market Forecast
  • 11.5 Middle East and Africa
    • 11.5.1 Market Trends
    • 11.5.2 Market Breakup by Country
    • 11.5.3 Market Forecast

12 SWOT Analysis

  • 12.1 Overview
  • 12.2 Strengths
  • 12.3 Weaknesses
  • 12.4 Opportunities
  • 12.5 Threats

13 Value Chain Analysis

14 Porters Five Forces Analysis

  • 14.1 Overview
  • 14.2 Bargaining Power of Buyers
  • 14.3 Bargaining Power of Suppliers
  • 14.4 Degree of Competition
  • 14.5 Threat of New Entrants
  • 14.6 Threat of Substitutes

15 Price Analysis

16 Competitive Landscape

  • 16.1 Market Structure
  • 16.2 Key Players
  • 16.3 Profiles of Key Players
    • 16.3.1 Aclaris Therapeutics Inc.
      • 16.3.1.1 Company Overview
      • 16.3.1.2 Product Portfolio
      • 16.3.1.3 Financials
    • 16.3.2 Cellmid Limited
      • 16.3.2.1 Company Overview
      • 16.3.2.2 Product Portfolio
      • 16.3.2.3 Financials
    • 16.3.3 Cipla Limited
      • 16.3.3.1 Company Overview
      • 16.3.3.2 Product Portfolio
      • 16.3.3.3 Financials
      • 16.3.3.4 SWOT Analysis
    • 16.3.4 Dr. Reddy's Laboratories Ltd.
      • 16.3.4.1 Company Overview
      • 16.3.4.2 Product Portfolio
      • 16.3.4.3 Financials
      • 16.3.4.4 SWOT Analysis
    • 16.3.5 GlaxoSmithKline plc
      • 16.3.5.1 Company Overview
      • 16.3.5.2 Product Portfolio
      • 16.3.5.3 Financials
      • 16.3.5.4 SWOT Analysis
    • 16.3.6 HCell Inc.
      • 16.3.6.1 Company Overview
      • 16.3.6.2 Product Portfolio
    • 16.3.7 Johnson & Johnson
      • 16.3.7.1 Company Overview
      • 16.3.7.2 Product Portfolio
      • 16.3.7.3 Financials
      • 16.3.7.4 SWOT Analysis
    • 16.3.8 Merck & Co. Inc.
      • 16.3.8.1 Company Overview
      • 16.3.8.2 Product Portfolio
      • 16.3.8.3 Financials
      • 16.3.8.4 SWOT Analysis
    • 16.3.9 Pfizer Inc.
      • 16.3.9.1 Company Overview
      • 16.3.9.2 Product Portfolio
      • 16.3.9.3 Financials
      • 16.3.9.4 SWOT Analysis
    • 16.3.10 Taisho Pharmaceutical Holdings Co. Ltd
      • 16.3.10.1 Company Overview
      • 16.3.10.2 Product Portfolio
      • 16.3.10.3 Financials
    • 16.3.11 Teva Pharmaceutical Industries Ltd.
      • 16.3.11.1 Company Overview
      • 16.3.11.2 Product Portfolio
      • 16.3.11.3 Financials
      • 16.3.11.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Alopecia Treatment Market: Major Drivers and Challenges
  • Figure 2: Global: Alopecia Treatment Market: Sales Value (in Billion US$), 2017-2022
  • Figure 3: Global: Alopecia Treatment Market Forecast: Sales Value (in Billion US$), 2023-2028
  • Figure 4: Global: Alopecia Treatment Market: Breakup by Drug Type (in %), 2022
  • Figure 5: Global: Alopecia Treatment Market: Breakup by Indication (in %), 2022
  • Figure 6: Global: Alopecia Treatment Market: Breakup by Gender (in %), 2022
  • Figure 7: Global: Alopecia Treatment Market: Breakup by Route of Administration (in %), 2022
  • Figure 8: Global: Alopecia Treatment Market: Breakup by Distribution Channel (in %), 2022
  • Figure 9: Global: Alopecia Treatment Market: Breakup by Region (in %), 2022
  • Figure 10: Global: Alopecia Treatment (Minoxidil) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 11: Global: Alopecia Treatment (Minoxidil) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 12: Global: Alopecia Treatment (Finasteride) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 13: Global: Alopecia Treatment (Finasteride) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 14: Global: Alopecia Treatment (Other Drug Types) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 15: Global: Alopecia Treatment (Other Drug Types) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 16: Global: Alopecia Treatment (Androgenic Alopecia) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 17: Global: Alopecia Treatment (Androgenic Alopecia) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 18: Global: Alopecia Treatment (Alopecia Areata) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 19: Global: Alopecia Treatment (Alopecia Areata) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 20: Global: Alopecia Treatment (Alopecia Totalis) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 21: Global: Alopecia Treatment (Alopecia Totalis) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 22: Global: Alopecia Treatment (Other Indications) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 23: Global: Alopecia Treatment (Other Indications) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 24: Global: Alopecia Treatment (Male) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 25: Global: Alopecia Treatment (Male) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 26: Global: Alopecia Treatment (Female) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 27: Global: Alopecia Treatment (Female) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 28: Global: Alopecia Treatment (Oral) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 29: Global: Alopecia Treatment (Oral) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 30: Global: Alopecia Treatment (Topical) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 31: Global: Alopecia Treatment (Topical) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 32: Global: Alopecia Treatment (Injectable) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 33: Global: Alopecia Treatment (Injectable) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 34: Global: Alopecia Treatment (Hospitals) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 35: Global: Alopecia Treatment (Hospitals) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 36: Global: Alopecia Treatment (Retail Pharmacies) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 37: Global: Alopecia Treatment (Retail Pharmacies) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 38: Global: Alopecia Treatment (Online Pharmacies) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 39: Global: Alopecia Treatment (Online Pharmacies) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 40: North America: Alopecia Treatment Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 41: North America: Alopecia Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 42: United States: Alopecia Treatment Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 43: United States: Alopecia Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 44: Canada: Alopecia Treatment Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 45: Canada: Alopecia Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 46: Asia-Pacific: Alopecia Treatment Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 47: Asia-Pacific: Alopecia Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 48: China: Alopecia Treatment Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 49: China: Alopecia Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 50: Japan: Alopecia Treatment Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 51: Japan: Alopecia Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 52: India: Alopecia Treatment Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 53: India: Alopecia Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 54: South Korea: Alopecia Treatment Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 55: South Korea: Alopecia Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 56: Australia: Alopecia Treatment Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 57: Australia: Alopecia Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 58: Indonesia: Alopecia Treatment Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 59: Indonesia: Alopecia Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 60: Others: Alopecia Treatment Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 61: Others: Alopecia Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 62: Europe: Alopecia Treatment Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 63: Europe: Alopecia Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 64: Germany: Alopecia Treatment Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 65: Germany: Alopecia Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 66: France: Alopecia Treatment Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 67: France: Alopecia Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 68: United Kingdom: Alopecia Treatment Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 69: United Kingdom: Alopecia Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 70: Italy: Alopecia Treatment Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 71: Italy: Alopecia Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 72: Spain: Alopecia Treatment Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 73: Spain: Alopecia Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 74: Russia: Alopecia Treatment Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 75: Russia: Alopecia Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 76: Others: Alopecia Treatment Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 77: Others: Alopecia Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 78: Latin America: Alopecia Treatment Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 79: Latin America: Alopecia Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 80: Brazil: Alopecia Treatment Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 81: Brazil: Alopecia Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 82: Mexico: Alopecia Treatment Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 83: Mexico: Alopecia Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 84: Others: Alopecia Treatment Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 85: Others: Alopecia Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 86: Middle East and Africa: Alopecia Treatment Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 87: Middle East and Africa: Alopecia Treatment Market: Breakup by Country (in %), 2022
  • Figure 88: Middle East and Africa: Alopecia Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 89: Global: Alopecia Treatment Industry: SWOT Analysis
  • Figure 90: Global: Alopecia Treatment Industry: Value Chain Analysis
  • Figure 91: Global: Alopecia Treatment Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Alopecia Treatment Market: Key Industry Highlights, 2022 and 2028
  • Table 2: Global: Alopecia Treatment Market Forecast: Breakup by Drug Type (in Million US$), 2023-2028
  • Table 3: Global: Alopecia Treatment Market Forecast: Breakup by Indication (in Million US$), 2023-2028
  • Table 4: Global: Alopecia Treatment Market Forecast: Breakup by Gender (in Million US$), 2023-2028
  • Table 5: Global: Alopecia Treatment Market Forecast: Breakup by Route of Administration (in Million US$), 2023-2028
  • Table 6: Global: Alopecia Treatment Market Forecast: Breakup by Distribution Channel (in Million US$), 2023-2028
  • Table 7: Global: Alopecia Treatment Market Forecast: Breakup by Region (in Million US$), 2023-2028
  • Table 8: Global: Alopecia Treatment Market: Competitive Structure
  • Table 9: Global: Alopecia Treatment Market: Key Players